Life Science Company MaxCyte Relocating HQ to Rockville, Md.

Life Science Company MaxCyte Relocating HQ to Rockville, Md.

Sponsored by DPR Construction

MaxCyte, a life science company specializing in cell-engineering technology, is relocating from Gaithersburg, Md., to Rockville, Md., Commercial Observer has learned. 

The company signed a 13-year, 67,000-square-foot lease at 9713 Key West Avenue, a five-story, 120,000-square-foot office building, with landlord Beckham Gumbin Ventures.

The biotechnology company’s current offices, totaling 37,000 square feet, are located at 21 and 22 Firstfield Road in Gaithersburg.

Edge represented the tenant in the lease. The rent was not disclosed.

Click here to read more via Commercial Observer.

Discover the latest projects making an impact in the region and the companies building them.
Click below…

Latest

How Structured Data and AI Are Reshaping Antibody Development and Tomorrow’s Therapeutics

EDITORS NOTE: All content, references and quotes for this...

Why Big AI Needs Biotech: Anthropic’s $400M Bet Reveals the Race for Proprietary Data Moats

Anthropic's $400 million acquisition of Coefficient Bio signals that...

Nathan Roman Named Market Activator for Greater Philadelphia at BioBuzz

Life sciences validation expert to lead ecosystem engagement and...

Newsletter

spot_img

Don't miss

How Structured Data and AI Are Reshaping Antibody Development and Tomorrow’s Therapeutics

EDITORS NOTE: All content, references and quotes for this...

Why Big AI Needs Biotech: Anthropic’s $400M Bet Reveals the Race for Proprietary Data Moats

Anthropic's $400 million acquisition of Coefficient Bio signals that...

Nathan Roman Named Market Activator for Greater Philadelphia at BioBuzz

Life sciences validation expert to lead ecosystem engagement and...

A Neuro Hub in the Making: Baltimore’s Ecosystem Begins to Coalesce at 4MLK

Baltimore’s life sciences ecosystem is entering a more defined...
spot_imgspot_img

How Structured Data and AI Are Reshaping Antibody Development and Tomorrow’s Therapeutics

EDITORS NOTE: All content, references and quotes for this article were gathered from the Benchling Case study as well as other available online sources. ‘In...

5 Questions With Angela Fernandez Iglesias, founder of Ciencia con Acento, and Editorial and Insights Contributor Ambassador for BioBuzz

Angela Fernandez Iglesias is a bilingual science communicator, strategist, and ecosystem builder based in Philadelphia. For most of her career she was a bench scientist....

Why Big AI Needs Biotech: Anthropic’s $400M Bet Reveals the Race for Proprietary Data Moats

Anthropic's $400 million acquisition of Coefficient Bio signals that the future of AI dominance hinges on access to proprietary domain-specific data. As foundation models...

Leave a Reply

Discover more from News

Subscribe now to keep reading and get access to the full archive.

Continue reading